BeStock  
Stocks › Biotechnology › OCS

Oculis OCS

US equityMarket cap rank #3648Biotechnology
$7.06 −$0.38 (-5.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.06 0.00%
Open$7.38
Prev close$7.44
Day range$6.98 – $7.43
Volume235.2K
Market cap$437.15M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$39.67+461.9% vs. price
  • Buy 100%
Low $39.00Now $7.06Avg $39.67High $40.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $45.00, averaging $36.26.

DateFirmRatingTarget
4 Nov 2026 BofA Securities BUY –
4 Nov 2026 Stifel BUY $40.00
4 Nov 2026 H.C. Wainwright BUY $39.00
3 Nov 2026 Guggenheim BUY $40.00
20 Oct 2026 H.C. Wainwright BUY $39.00
12 Oct 2026 BofA Securities BUY $32.00
28 Sep 2026 Stifel BUY $40.00
18 Sep 2026 H.C. Wainwright BUY $39.00
25 Aug 2026 H.C. Wainwright BUY $26.00
24 Aug 2026 H.C. Wainwright BUY $26.00
14 Aug 2026 Stifel BUY $40.00
14 Aug 2026 J.P. Morgan BUY $20.00
10 Aug 2026 H.C. Wainwright BUY $26.00
8 Aug 2026 LifeSci Capital BUY $41.00
7 Aug 2026 BofA Securities BUY $32.00
7 Aug 2026 Stifel BUY $40.00
7 Aug 2026 Needham BUY $38.00
6 Aug 2026 LifeSci Capital BUY $41.00
6 Aug 2026 Guggenheim BUY $45.00
5 Aug 2026 LifeSci Capital BUY $45.00

Discussion

No comments yet — be the first to weigh in on OCS.

Sign in to join the discussion.

Scroll to Top